<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35562348</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2041-4889</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>13</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cell death &amp; disease</Title>
          <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway.</ArticleTitle>
        <Pagination>
          <StartPage>458</StartPage>
          <MedlinePgn>458</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">458</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-022-04865-y</ELocationID>
        <Abstract>
          <AbstractText>Prostate cancer (PCa) is one of the major malignant tumors among men worldwide. Long noncoding RNAs (lncRNAs) have been documented as important modulators in human cancers, including PCa. In our study, we investigated the role and potential mechanism of RP1-59D14.5 in PCa. RP1-59D14.5 expressed at a low level in PCa cells. Gain-of-function assays including colony formation and transwell assays displayed that RP1-59D14.5 overexpression repressed PCa cell proliferation, migration, and invasion. Besides, RP1-59D14.5 up-regulation induced autophagy in PCa cells. Mechanically, luciferase reporter assays and western blot verified that RP1-59D14.5 activated the Hippo pathway in PCa cells. Through RNA-binding protein immunoprecipitation (RIP) and RNA pull-down assays, we validated that RP1-59D14.5 functioned as a competing endogenous RNA (ceRNA) to regulate large tumor suppressor kinase 1/2 (LATS1/2) via targeting miR-147a. Moreover, RP1-59D14.5 recruited HUR to promote casein kinase 1 (CK1) expression. Collectively, RP1-59D14.5 promoted yes-associated protein (YAP) degradation to activate the Hippo pathway in PCa progression via targeting the miR-147a/LATS1/2 axis and recruiting HUR to promote the interaction of CK1 and β-transducin repeat-containing protein (βTrCP). These results implied that RP1-59D14.5 acted as a tumor suppressor in PCa, which might be a target for PCa treatment.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Bing</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Zexue</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0003-1344-7701</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics, the Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China. zhaozexue2012@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-8997-9694</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China. xi56528931@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cell Death Dis</MedlineTA>
        <NlmUniqueID>101524092</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>23</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35562348</ArticleId>
        <ArticleId IdType="pmc">PMC9106715</ArticleId>
        <ArticleId IdType="doi">10.1038/s41419-022-04865-y</ArticleId>
        <ArticleId IdType="pii">10.1038/s41419-022-04865-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32:1105–40. doi: 10.1101/gad.315739.118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.315739.118</ArticleId>
            <ArticleId IdType="pmc">PMC6120714</ArticleId>
            <ArticleId IdType="pubmed">30181359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, Yang XQ, Han CT, Dai B, Zhang HL, Shi GH, et al.  Pathological features of localized prostate cancer in China: a contemporary analysis of radical prostatectomy specimens. PloS one. 2015;10:e0121076. doi: 10.1371/journal.pone.0121076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0121076</ArticleId>
            <ArticleId IdType="pmc">PMC4370496</ArticleId>
            <ArticleId IdType="pubmed">25799190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen-Nielsen M, Borre M. Diagnostic and therapeutic strategies for prostate cancer. Semin Nucl Med. 2016;46:484–90. doi: 10.1053/j.semnuclmed.2016.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.semnuclmed.2016.07.002</ArticleId>
            <ArticleId IdType="pubmed">27825428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patil N, Gaitonde K. Clinical perspective of prostate cancer. Top Magn Reson Imaging: TMRI. 2016;25:103–8. doi: 10.1097/RMR.0000000000000091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RMR.0000000000000091</ArticleId>
            <ArticleId IdType="pubmed">27187167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jathar S, Kumar V, Srivastava J, Tripathi V. Technological developments in lncRNA biology. Adv Exp Med Biol. 2017;1008:283–323. doi: 10.1007/978-981-10-5203-3_10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-981-10-5203-3_10</ArticleId>
            <ArticleId IdType="pubmed">28815544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–81. doi: 10.1158/0008-5472.CAN-16-2634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-16-2634</ArticleId>
            <ArticleId IdType="pmc">PMC8330958</ArticleId>
            <ArticleId IdType="pubmed">28701486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandra Gupta S, Nandan, Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140:1955–67. doi: 10.1002/ijc.30546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.30546</ArticleId>
            <ArticleId IdType="pubmed">27925173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X, Xiao Y, Zhou Y, Zhou Z, Yan W. lncRNA SNHG20 promotes prostate cancer migration and invasion via targeting the miR-6516-5p/SCGB2A1 axis. Am J Transl Res. 2019;11:5162–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6731428</ArticleId>
            <ArticleId IdType="pubmed">31497231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua X, Liu Z, Zhou M, Tian Y, Zhao PP, Pan WH, et al.  LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN. EBioMedicine. 2019;50:178–90. doi: 10.1016/j.ebiom.2019.10.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2019.10.009</ArticleId>
            <ArticleId IdType="pmc">PMC6921238</ArticleId>
            <ArticleId IdType="pubmed">31727599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YC, He WY, Dong CH, Pei L, Ma YL. lncRNA HCG11 regulates cell progression by targeting miR-543 and regulating AKT/mTOR pathway in prostate cancer. Cell biology international. 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang C, Wang GX, Fu B, Zhou XC, Li Y, Li YY. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p. Eur Rev Med Pharmacol Sci. 2019;23:8303–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31646560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393–407. doi: 10.1016/j.cell.2018.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2018.01.011</ArticleId>
            <ArticleId IdType="pmc">PMC5978744</ArticleId>
            <ArticleId IdType="pubmed">29373828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv. 2017;3:eaao2110. doi: 10.1126/sciadv.aao2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/sciadv.aao2110</ArticleId>
            <ArticleId IdType="pmc">PMC5617379</ArticleId>
            <ArticleId IdType="pubmed">28959731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726–34. doi: 10.1038/nrc1692.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc1692</ArticleId>
            <ArticleId IdType="pubmed">16148885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J, Zhang HB, Shi Q, Yang C, Ma JB, Jin B, et al.  KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy. Theranostics. 2019;9:5464–77. doi: 10.7150/thno.33282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.33282</ArticleId>
            <ArticleId IdType="pmc">PMC6735397</ArticleId>
            <ArticleId IdType="pubmed">31534497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma S, Meng Z, Chen R, Guan KL. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577–604. doi: 10.1146/annurev-biochem-013118-111829.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-biochem-013118-111829</ArticleId>
            <ArticleId IdType="pubmed">30566373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, et al.  Overexpression of Rac GTPase activating protein 1 contributes to proliferation of cancer cells by reducing hippo signaling to promote cytokinesis. Gastroenterology. 2018;155:1233–49.e22. doi: 10.1053/j.gastro.2018.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2018.07.010</ArticleId>
            <ArticleId IdType="pubmed">30009820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13:877–83. doi: 10.1038/ncb2303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb2303</ArticleId>
            <ArticleId IdType="pmc">PMC3987945</ArticleId>
            <ArticleId IdType="pubmed">21808241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, et al.  LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun. 2019;10:2571. doi: 10.1038/s41467-019-09784-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-09784-9</ArticleId>
            <ArticleId IdType="pmc">PMC6561926</ArticleId>
            <ArticleId IdType="pubmed">31189930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) Genes Dev. 2010;24:72–85. doi: 10.1101/gad.1843810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1843810</ArticleId>
            <ArticleId IdType="pmc">PMC2802193</ArticleId>
            <ArticleId IdType="pubmed">20048001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, et al.  The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013;45:1392–8. doi: 10.1038/ng.2771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.2771</ArticleId>
            <ArticleId IdType="pmc">PMC3812362</ArticleId>
            <ArticleId IdType="pubmed">24076601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik R, Patel L, Prensner JR, Shi Y, Iyer MK, Subramaniyan S, et al.  The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol Cancer Res: MCR. 2014;12:1081–7. doi: 10.1158/1541-7786.MCR-14-0257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-14-0257</ArticleId>
            <ArticleId IdType="pmc">PMC4135019</ArticleId>
            <ArticleId IdType="pubmed">25030374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, et al.  lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. The. FEBS J. 2014;281:3766–75. doi: 10.1111/febs.12902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.12902</ArticleId>
            <ArticleId IdType="pubmed">24988946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai CJ, Lin CY, Liao WY, Hour TC, Wang HD, Chuu CP. CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling. Cells. 2019;8.</Citation>
        </Reference>
        <Reference>
          <Citation>Lam-Himlin DM, Daniels JA, Gayyed MF, Dong J, Maitra A, Pan D, et al.  The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006;37:103–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18175224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi BR, Kim TH, Kim YS, Choi KC. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers. Int J Oncol. 2015;46:272–80. doi: 10.3892/ijo.2014.2695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijo.2014.2695</ArticleId>
            <ArticleId IdType="pubmed">25310727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–8. doi: 10.1016/j.cell.2011.07.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2011.07.014</ArticleId>
            <ArticleId IdType="pmc">PMC3235919</ArticleId>
            <ArticleId IdType="pubmed">21802130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y, Luan XR miR-147a suppresses the metastasis of non-small-cell lung cancer by targeting CCL5. J Int Med Res. 2019:300060519883098.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang J. CK1 in developmental signaling: Hedgehog and Wnt. Curr Top developmental Biol. 2017;123:303–29. doi: 10.1016/bs.ctdb.2016.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.ctdb.2016.09.002</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
